Skip to main content

Table 4 Serum biochemistry parameters of male and female rats in the chronic toxicity evaluation of the CMC-AL in comparison with control. Data are presented as median (range with 95%CI) of twenty rats

From: Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of Atractylodes lancea (Thunb.) DC

Parameters

Control

CMC-AL (mg/kg bw.)

1,000

3,000

5,000

Male

Female

Male

Female

Male

Female

Male

Female

Total protein (g/dl) *

7.4 (7.2–8.1)

8.4 (8.1–9.0)

8.3 (7.5–8.9)*

7.6 (7.3–8.6)*

8.1 (7.7–9.0)*

7.3 (6.8–8.2)*

7.9 (7.5–9.0)*

7.2 (6.9–8.1)*

AST (U/l) *

119.9 (108.6–140.2)

222.0 (214.4–238.6)

125.2 (117.8–143.8)

230.23 (209.7–257.4)

145.3 (138.6–170.2)*

219.5 (208.4–240.3)

150.7 (140.9–178.5)*

228.6 (210.6–245.0)

ALT (U/l) *

89.7 (76.2–102.5)

103.5 (85.4–125.6)

92.4 (79.7–110.3)

99.3 (87.9–119.8)

111.6 (102.6–124.7)*

108.2 (99.5–122.6)

117.8 (108.9–130.6)*

107.1 (97.2–116.4)

Cholesterol (mg/dl) *

162.6 (145.3–186.7)

137.0 (119.5–157.6)

165.7.0 (140.8–198.6)

140.1 (121.7–169.5)

168.5 (156.1–189.5)

169.6 (154.2–203.9)*

164.2 (143.8–195.6)

185.3 (157.6–217.8)*

BUN (mg/dl) *

18.5 (17.4–19.2)

19.9 (19.3–20.6)

18.2 (17.8–19.1)

19.4 (19.1–20.7)

19.0 (18.8–20.7) *

19.7 (19.2–20.6)

20.4 (19.1–21.3) *

19.5 (18.8–20.5)

Creatinine (mg/dl)

0.5 (0.42–0.57)

0.4 (0.35–0.46)

0.5 (0.41–0.56)

0.4 (0.36–0.50)

0.5 (0.45–0.62)

0.4 (0.32–0.51)

0.5 (0.44–0.58)

0.4 (0.32–0.49)

Albumin (g/dl) *

4.4 (4.0–5.1)

5.9 (5.5–6.3)

4.3 (4.0–4.9)

5.8 (5.3–6.2)

4.5 (4.3–5.1)

5.9 (5.5–7.2)

6.7 (6.3–7.9)*

6.0 (5.7–6.7)

Globulin (g/dl)

2.8 (2.45–2.96)

1.9 (1.35–1.98)

2.7 (2.38–2.92)

2.0 (1.67–2.08)

2.5 (2.23–2.86)

1.8 (1.67–2.03)

2.9 (2.59–3.13)

2.0 (1.75–2.11)

ALP (U/l)

75.0 (68.43–81.95)

43.0 (40.04–46.74)

69.0 (67.76–80.24)

45.5 (41.82–49.35)

72.0 (67.47–82.03)

48.1 (41.62–50.71)

74.0 (69.68–82.35)

47.7 (44.93–49.05)

Glucose (mg/dl) *

389.4 (342.3–501.0)

271.3 (224.5–357.8)

455.2 (397.2–556.4)*

299.7 (267.4–402.8)*

442.8 (370.6–564.3)*

324.3 (247.6–407.8)*

492.4 (375.6–614.7)*

348.9 (297.6–426.5)*

Uric acid (mg/dl)

13.1 (12.74–14.21)

8.5 (8.16–8.93)

13.4 (13.06–14.31)

8.2 (7.98–8.67)

13.5 (13.22–13.99)

8.0 (7.75–8.46)

13.7 (13.31–14.25)

8.4 (7.98–8.65)

Triglycerides (mg/dl) *

210.6 (176.5–243.7)

244.1 (202.7–289.6)

215.4 (198.7–257.8)

239.5 (227.6–295.7)

217.6 (186.2–236.9)

251.7 (186.3–299.4)

204.1 (190.6–245.7)

304.5 (257.4–412.3)*

  1. * Significantly different from the control group